Nebivolol is a selective beta-adrenergic antagonist used primarily to manage high blood pressure. It blocks beta-1 receptors in the heart to reduce heart rate and cardiac output. By antagonizing beta-2 receptors it also promotes vasodilation through increased nitric oxide production. This dual action helps lower peripheral vascular resistance and improves endothelial function. The medication is taken orally as a once-daily tablet to provide sustained antihypertensive effects. Its long half-life allows consistent blood pressure control throughout the day. Nebivolol does not significantly affect metabolic parameters such as glucose or lipid levels. Overall the drug works by modulating sympathetic nervous system activity to achieve therapeutic blood pressure reduction.

Nebivolol is a selective beta-adrenergic receptor antagonist used primarily to treat hypertension and heart failure. Its pharmacological action involves blocking type-1 adrenergic receptors that mediate sympathetic nervous system activity. By reducing the response to catecholamines, the drug lowers heart rate and cardiac output. Nebivolol also promotes nitric oxide production in the endothelium, leading to vasodilation of peripheral blood vessels. This combined effect improves blood flow and reduces peripheral resistance, contributing to its antihypertensive efficacy. The medication is employed clinically to manage high blood pressure and related cardiovascular conditions.

Many individuals experience mild fatigue following treatment. Headache and nausea are frequently reported during the first week. Some people notice temporary dizziness when adjusting dosage. Mild skin irritation may occur at topical application sites. These effects often diminish as the body adapts. Most users observe improvement after several days of continued use.

The most common side effects include mild headache dizziness fatigue and nausea. These reactions are usually temporary and resolve without intervention. They often occur shortly after exposure and may vary between individuals. Headache and fatigue are frequently reported in clinical observations. Nausea and mild stomach discomfort are also observed in many cases. Overall the incidence of these effects remains low across diverse populations.